I really can't see the distinction here between a medical device maker that gets FDA approval being absolved of any liability and a drug maker who gets approval from the same agency (through a stricter review process) being held liable. What am I missing? Shouldn't the pharmaceutical industry be making a big deal about this Supreme Court ruling and the apparent precedent it opens up given the huge litigation bills they have faced in recent years?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.